COMMUNIQUÉS West-GlobeNewswire

-
Press Release: Sanofi accelerates global shipping of Beyfortus to prepare healthcare providers months ahead of 2025-2026 RSV season
09/06/2025 -
MISE À JOUR DES MODALITÉS DE L’ASSEMBLÉE GÉNÉRALE
09/06/2025 -
UPDATE ON THE TERMS OF THE SHAREHOLDERS GENERAL MEETING
09/06/2025 -
AB Science annonce l’approbation par l’EMA de la prolongation de la durée de conservation de Masivet à 4 ans
09/06/2025 -
AB Science announces EMA approval of Masivet shelf-life extension to 4 years
09/06/2025 -
Dupixent® (dupilumab) Data at Revolutionizing Atopic Dermatitis (RAD) Conference Reinforce Use in Atopic Dermatitis Patients with Skin of Color
08/06/2025 -
Ro Weight Loss Announces Official Website Update Featuring Natural Daily Program for Medically-Guided Weight Management
07/06/2025 -
Collaboration entre OBI Pharma et TegMine Therapeutics autour des ADC, reposant sur les technologies habilitantes GlycOBI® et TegMiner™
06/06/2025 -
Zealand Pharma increases its share capital as a result of the exercise of employee warrants
06/06/2025 -
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06/06/2025 -
Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06/06/2025 -
Keros Therapeutics Announces Participation at Goldman Sachs 46th Annual Global Healthcare Conference
06/06/2025 -
Enovis to Participate in Upcoming Investor Conferences
06/06/2025 -
TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
06/06/2025 -
PolyPid to Host Conference Call and Webcast to Discuss D-PLEX₁₀₀ SHIELD II Phase 3 Trial Topline Results on Monday, June 9, 2025
06/06/2025 -
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06/06/2025 -
RESTEM to Present Phase 2/3 IIMPACT Trial Design in Idiopathic Inflammatory Myopathy at EULAR 2025 Congress
06/06/2025 -
Rakovina Therapeutics Announces the Closing of Oversubscribed Private Placement of $4.9 Million
06/06/2025 -
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06/06/2025
Pages